Gordon Lavigne, MEd, CEO of the Schizophrenia & Psychosis Action Alliance, talk about the joint FDA committee's vote on clozapine REMS.
Gordon Lavigne, MEd
Advertisement
Mr Lavigne is the chief executive officer of the Schizophrenia & Psychosis Action Alliance.
Articles by Gordon Lavigne, MEd
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Precision Diagnosis: The New Paradigm for Neurocognitive Disorders
2
Healing From the Iceberg of Moral Injuries During the Mideast Peace Plan Ceasefire
3
Social Determinants of Health and Mental Health (II): Evaluation, Political Perspectives and Global Implications
4
